Ann: Application for quotation of securities - PAA, page-27

While we are talking T/O I wonder if a deal could be done for the whole of PAA for cash or shares or whatever, but then also attach an additional new class of shares in the buying company. That new class of shares may be worth, say 1 cent, but would have royalty revenues attached to them for any and all sales of MPL related products, regardless of the end use.
This would allow a simple deal to happen and allow both parties to monetise the tangible/de-risked/near-term MND treatment. Yet it would also give value to the pie in the sky treatments that most of us are wary about flogging off.
The only downside would be that it might complicate the buying companies share structure, yet these big companies tend to have multiple classes anyway so why not add one more forbthe sake of 80 new possible treatments.
They could alternatively put it all in a subsidiary newco.